TNF Blocker Lawsuit
TNF Blocker Information
The FDA has completed an analysis of possible side effects caused by a class of drugs known as TNF blockers.
These medications include;
The FDA has concluded that there is an increased risk of lymphoma and other cancers in children and adolescents who are given these medications.
TNF (Tumor Necrosis Factor) blockers are immune system suppressants that are used to treat;
* Juvenile Idiopathic Arthritis (JIA)
* Rheumatoid Arthritis
* Psoriatic Arthritis
* Plaque Psoriasis
* Crohn’s Disease
The FDA has looked examined at least thirty cases reported over the decade 1998 – 2008 of cancer development in children and adolescents who have been treated with this medication.
In 2006 the FDA acted on reports of adverse effects from TNF blockers, and ordered that a black box warning be printed on the packaging for these drugs that the patient is at risk for the development of fungus infections. There are also currently warnings on the packaging for these products that cite the possibility of malignancy, but do not specifically address lymphoma.
There has been a fair amount of controversy over these medications and several FDA actions taken requiring labeling of the products. Nevertheless they remain in production and circulation, in part because they are major revenue sources for the companies that manufacture and distribute them. Humira had over $3 billion in sales last year, while Remicade led its manufacturer’s list of profit centers with $1.65 billion in sales.
If you or a family member has developed further medical problems as the result of taking one of these TNF blockers, you should discuss the matter with an experienced drug liability attorney. Contact our office today and we will provide you with an up to date review of your case at no charge.